J9190 – Injection, fluorouracil, 500 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9190
- Long description
- Injection, fluorouracil, 500 mg
- Short description
- Fluorouracil injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 1984
- Last change
- October 1, 2026 – Discontinued
- Termination date
- September 30, 2026
Frequently asked questions
What is HCPCS code J9190?
J9190 is a HCPCS Level II code for injection, fluorouracil, 500 mg. It was discontinued on September 30, 2026.
Does Medicare cover J9190?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9178 – Injection, epirubicin hcl, 2 mg
- J9179 – Injection, eribulin mesylate, 0.1 mg
- J9181 – Injection, etoposide, 10 mg
- J9183 – Gemcitabine intravesical system, 225 mg
- J9184 – Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9185 – Injection, fludarabine phosphate, 50 mg
- J9186 – Injection, etoposide (avyxa), 1 mg
- J9187 – Injection, etoposide, 1 mg
- J9191 – Injection, fluorouracil (avyxa), 10 mg
- J9192 – Injection, fluorouracil, 10 mg
- J9196 – Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
- J9198 – Injection, gemcitabine hydrochloride, (infugem), 100 mg
- J9199 – Injection, gemcitabine hydrochloride (infugem), 200 mg
- J9200 – Injection, floxuridine, 500 mg
- J9201 – Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 – Goserelin acetate implant, per 3.6 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.